💨 Abstract

On May 13, 2025, Elicio Therapeutics, Inc. (ELTX) reported a first-quarter loss of $11.2 million, equivalent to 87 cents per share. The Boston-based company's financial results were automatically generated using data from Zacks Investment Research. Further stock information can be accessed via Zacks' website.

Courtesy: wtop.com